The global targeted DNA/RNA sequencing market is
expected to reach USD 15.9 billion by 2025. Targeted Sequencing has emerged as
a key technology in life science research by enabling examination of specific
region of interest while keeping the seq. cost as well as complexity of data
under manageable limits.
Request
A Sample Copy Of This Report at: https://www.radiantinsights.com/research/targeted-dna-rna-sequencing-market/request-sample
This approach enhances sequencing depth by allowing
evaluation of specific coding regions within genes or specific genes, which are
known to harbor mutations for disease pathogenesis. Several research projects
have employed this technology to avoid wastage of information and extra cost and
study only relevant genes. Number of such projects continue to grow,
consequently driving the market.
Innovations to address the pitfalls of targeted
enrichment method are anticipated to enhance the usage rate of this technology
throughout the forecast period. Moreover, with decrease in seq-cost and
improvement in informatics, targeted methods have become more accessible for
use in clinical settings than ever.
Further
key findings from the report suggest:
• Next-Generation Sequencing (NGS) technology
captured a major share in 2016
• Rapid advancements in NGS and its ancillary
protocols can be attributed to the growth of this segment
• Out of all the NGS-based targeted methods,
exome-seq held the largest share
• This can be attributed to the fact that though it
accounts for less than 2% of the genome, it contains 85% of the known
disease-relevant variants
• Entire targeted approach is broken down into
presequencing, sequence determination, and data analysis
• Being the most crucial step, sequencing accounted
for the largest share
• This space has revolutionized various applications
of life sciences, including human biomedical research, plant & animal
sciences, drug discovery, and others
• Out of all, human biomedical research is estimated
to be the largest application of this space due its high usage in studying
disease pathogenesis
• The market is bifurcated into DNA-seq and RNA-seq,
based on the sample type
• DNA-sequencing has been estimated to generate the
higher revenue over its counterpart segment. This can be attributed to the
presence of wide range of products and kits for DNA-seq
• As per end use, academic research is estimated to
be the largest segment owing to the increase in seq-based projects at
universities and other academic centers
• North America held the largest share owing to the
presence of effective regulations pertaining to approval of genetic tests and
bioinformatics tools
• Moreover, the U.S. is observed to have highest
number of installed sequencers, which in turn, has contributed to the large
share of North America regional market
Complete
Report Available @ https://www.radiantinsights.com/research/targeted-dna-rna-sequencing-market
About
Radiant Insights,Inc
Radiant Insights is a platform for companies looking
to meet their market research and business intelligence requirements. We assist
and facilitate organizations and individuals procure market research reports,
helping them in the decision making process. We have a comprehensive collection
of reports, covering over 40 key industries and a host of micro markets. In
addition to over extensive database of reports, our experienced research
coordinators also offer a host of ancillary services such as, research
partnerships/ tie-ups and customized research solutions.
Media
Contact:
Michelle Thoras
201 Spear Street 1100,
Suite 3036, San Francisco,
CA 94105, United States
Tel: 1-415-349-0054
Toll Free: 1-888-928-9744
Mail: sales@radiantinsights.com
Michelle Thoras
201 Spear Street 1100,
Suite 3036, San Francisco,
CA 94105, United States
Tel: 1-415-349-0054
Toll Free: 1-888-928-9744
Mail: sales@radiantinsights.com
No comments:
Post a Comment